Vanda Pharmaceuticals (VNDA) Payables (2016 - 2025)
Historic Payables for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q4 2025 value amounting to $68.3 million.
- Vanda Pharmaceuticals' Payables rose 7473.52% to $68.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $68.3 million, marking a year-over-year increase of 7473.52%. This contributed to the annual value of $68.3 million for FY2025, which is 7473.52% up from last year.
- As of Q4 2025, Vanda Pharmaceuticals' Payables stood at $68.3 million, which was up 7473.52% from $47.6 million recorded in Q3 2025.
- Vanda Pharmaceuticals' Payables' 5-year high stood at $68.3 million during Q4 2025, with a 5-year trough of $26.1 million in Q1 2021.
- In the last 5 years, Vanda Pharmaceuticals' Payables had a median value of $39.2 million in 2024 and averaged $41.7 million.
- In the last 5 years, Vanda Pharmaceuticals' Payables skyrocketed by 9687.42% in 2022 and then plummeted by 3644.2% in 2023.
- Over the past 5 years, Vanda Pharmaceuticals' Payables (Quarter) stood at $34.4 million in 2021, then skyrocketed by 32.27% to $45.6 million in 2022, then fell by 15.57% to $38.5 million in 2023, then rose by 1.63% to $39.1 million in 2024, then skyrocketed by 74.74% to $68.3 million in 2025.
- Its Payables was $68.3 million in Q4 2025, compared to $47.6 million in Q3 2025 and $57.1 million in Q2 2025.